Artificial intelligence is being utilized in the development of drugs for solid tumors, with applications in precision diagnosis and treatment. The technology is being explored for various uses, including mapping tumor immunity and optimizing vaccine engineering, as well as integrating with digital pathology and genomics for more precise treatments. The growth of ai in oncology is also reflected in the business sector, with companies involved in ai drug development generating significant investment.